Headlands Research Opens Twin Cities Clinical Research Site, Extending Upper-Midwest Reach for Sponsors and CROs

New location strengthens network's metabolic and respiratory franchise while giving sponsors single-contract access to patients across Minnesota and the broader region

WEST PALM BEACH, Fla. and ST. PAUL, Minn., Aug. 19, 2025 /PRNewswire/ -- Headlands Research, a leading multinational network of clinical trial sites, today announced the opening of Headlands Research Twin Cities (HRTC), its 23rd fully owned site. Strategically situated in the Minneapolis–St. Paul metro area, the new center offers pharmaceutical sponsors and CROs rapid, single-contract access to a wide range of Upper-Midwest patient populations.

"The Twin Cities are a major healthcare hub for the Upper Midwest," said Kyle Burtnett, CEO of Headlands Research. "Combining Principal Investigator Dr. Charlene McEvoy's extensive respiratory expertise with our network-wide technology, SOPs, and quality systems, we can help sponsors accelerate enrollment in sleep, pulmonology, metabolic, and general-medicine studies while maintaining the data integrity they expect."

HRTC will be led by Dr. McEvoy, a board-certified pulmonologist and sleep medicine specialist with over 25 years of experience in clinical research. Her established relationships with regional health systems and community organizations position the site to launch studies quickly, recruit and retain participants effectively, and meet trial endpoints with compliance. Sponsors will also benefit from Headlands Research's centralized contracting, validated data platforms, and 5,000-trial track record, eliminating the fragmentation often encountered when engaging independent sites.

"Patients in our region deserve earlier access to cutting-edge therapies," said Dr. McEvoy, Principal Investigator at HRTC. "Joining the Headlands network allows us to combine local trust and outreach with enterprise-grade operational support, bringing novel treatments to patients faster and more reliably."

The launch, which follows Headlands Research's recent expansion into Puerto Rico, deepens the company's presence across North America and reinforces its leadership in respiratory and endocrine/metabolic research. By expanding its Midwest footprint, Headlands Research can deliver faster study start-up and broader patient access for sponsors seeking high-quality data from a region known for its innovative health-care systems.

To discuss upcoming studies or learn more about Headlands Research Twin Cities, contact [email protected] or visit www.headlandsresearch.com.

About Headlands Research

Headlands Research is a multinational integrated clinical trial site organization with a mission to improve lives by advancing innovative medical therapies. Its group of exceptional sites focuses on large-volume recruitment of diverse and specialty patient populations while delivering the highest quality data. Headlands Research's principal investigators are proven industry leaders in their fields with expertise in a wide variety of indications. Utilizing expert recruitment strategies and access to diverse patients through its site databases and physician partnerships, Headlands Research has successfully completed more than 5,000 clinical trials. Additional information about the company is available at www.headlandsresearch.com.

Contact: Brittany Kearns
Phone: 571-271-7211
Email: [email protected]

SOURCE Headlands Research